With this transaction, Crown Laboratories acquires a portfolio of top-rated GSK products, including: PanOxyl®, a leading acne wash; Sarna, an anti-itch lotion; Zeasorb, an anti-fungal prevention product; Desenex®, an anti-fungal powder; and Mineral Ice®,a leading pain-relieving gel. All five brands have a longstanding reputation for quality and effectiveness, and three of them (PanOxyl, Sarna, and Zeasorb) have earned #1 Dermatologist Recommended status through decades of strong support from dermatologists.

The acquisition adds proven, well-recognized brands to Crown Laboratories’ portfolio of OTC products and enhances the breadth and value of the company’s trusted consumer skin care therapies. The deal also reinforces Hildred’s commitment to work with Crown to build a diversified business with high-quality dermatology and skin care products.